Hopfner Robert Lorne - Insider Non-Derivative Transactions at Inozyme Pharma, Inc. (INZY) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Aug 1, 2023, Hopfner Robert Lorne's relationship to Inozyme Pharma, Inc. (INZY) is Director, and currently has 2,923,110 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other INZY insiders.
Data Source: SEC.
Hopfner Robert Lorne - Insider Non-Derivative Transactions of INZY Common Stock
Hopfner Robert Lorne - Insider Non-Derivative Transactions at INZY
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Aug 2, 2023 | P -- (Common Stock) | 714285 | 4.8 | 1571741 |
| Aug 2, 2023 | P -- (Common Stock) | 119048 | 4.8 | 2923110 |
| May 13, 2023 | P -- (Common Stock) | 228702 | 6.25 | 3661518 |
| May 12, 2023 | P -- (Common Stock) | 219230 | 6.48 | 3432816 |
| Mar 30, 2023 | P -- (Common Stock) | 344592 | 4.54 | 3213586 |
| Mar 29, 2023 | P -- (Common Stock) | 156766 | 4.16 | 2868994 |
| Mar 28, 2023 | P -- (Common Stock) | 51074 | 3.7 | 2712228 |